PPT-DES-PCI was inferior to CABG for clinical outcomes at 5 years following revascularization

Author : arya | Published Date : 2024-02-02

lesions The hazard was highest with CABG in the first 30 days with better outcomes with PCI between 30 days and 5 years outcomes were inferior with PCI compared

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "DES-PCI was inferior to CABG for clinic..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

DES-PCI was inferior to CABG for clinical outcomes at 5 years following revascularization: Transcript

lesions The hazard was highest with CABG in the first 30 days with better outcomes with PCI between 30 days and 5 years outcomes were inferior with PCI compared with CABG CABG n 592. . . OMICS . Group is an amalgamation of . Open Access publications. and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 500 online open access . bypass grafting in treatment of unprotected left . main stenosis. Nordic–Baltic–British . left main . revascularisation study . (NOBLE. ). A . prospective, randomised, open-label. , non-inferiority trial. –. DEFINE-FLAIR . Justin E Davies, MD, . PhD on behalf of the DEFINE-FLAIR investigators. Hammersmith Hospital, . Imperial College London. F. unctional . L. esion . A. ssessment of . I. ntermediate stenosis to guide . vs. FFR-guided . Coronary Intervention . –. . iFR. -SWEDEHEART. Matthias Götberg, . MD, . PhD. Department of Cardiology, Lund University. Skane. University Hospital. Lund, Sweden. Disclosures. Volcano/Philips: Unrestricted grant to fund . The REAL-CAD Study in 13,054 Patients . With Stable Coronary Artery Disease . Disclosure: Public Health Research Foundation, Kowa Pharmaceutical Co. Ltd.. Takeshi Kimura, Teruo Inoue, Isao Taguchi, Hiroshi Iwata, Satoshi Iimuro, . a tale of two trials. SCTS University 2016. BRIAN BUXTON and . philip. . hayward. . . University of . Melbourne,. EPWORTH and . Clifford W. Barlow (FRCS, DPhil). Southampton General Hospital. Southampton, UK. Quality?. Quality and Outcomes differ for different individuals. Are you operating for survival or symptoms. Short-term: Survival . The REAL-CAD Study in 13,054 Patients . With Stable Coronary Artery Disease . Disclosure: Public Health Research Foundation, Kowa Pharmaceutical Co. Ltd.. Takeshi Kimura, Teruo Inoue, Isao Taguchi, Hiroshi Iwata, Satoshi Iimuro, . Revascularization in Stable Ischemic Heart Disease. Bobby Mathew, MD. LSU Internal Medicine, HO-II. Definitions. Recommendations for revascularization in the setting of symptomatic, stable ischemic heart disease; does not include revascularization in the setting of acute MI. . 2021 ACC/AHA/SCAI Guideline of Coronary Artery Revascularization. Table 1. . Applying. . ACC/AHA Class of Recommendation and Level of Evidence to Clinical Strategies, Interventions, Treatments, or Diagnostic Testing in Patient Care . vs.. . c. oronary artery bypass for multi-vessel disease: a meta-analysis. . Nirav C Patel MD, Jonathan M Hemli MD, Karthik Seetharam MD, Annapoorna Uttara BS, Derek R Brinster MD,. . Luigi Pirelli MD, Chad . On behalf of the PRECOMBAT Investigators. Professor of Medicine, University of Ulsan College of Medicine, . Heart Institute, Asan Medical Center, Seoul, Korea . PRECOMBAT Trial. Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using . iFR-Swedeheart. 5-year outcome. Matthias Götberg, MD, PhD. Skane. University Hospital, Lund University, Sweden. - on behalf of the . iFR-Swedeheart. investigators. Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below.. Kappetein. , Joseph F. . Sabik. , Patrick W. . Serruys. and the EXCEL investigators. EXCEL. Five-year Outcomes from a Randomized Trial of PCI vs. CABG in Patients with Left Main Coronary Artery Disease.

Download Document

Here is the link to download the presentation.
"DES-PCI was inferior to CABG for clinical outcomes at 5 years following revascularization"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.